Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Aralez Pharmaceuticals Inc. (ARLZ)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12
   10-K10-K10-K10-K10-KS-1/A
Revenues:  
    U.S.  79.230.121.432.4  
    Canada  26.824.2    
Total revenues   [+]105.954.321.432.40.00.0
            Revenue growth   [+]95.2%153.7%-34.0%   
Cost of goods sold   [+]47.824.40.015.80.00.0
Gross profit  58.129.921.416.60.00.0
            Gross margin  54.9%55.1%100.0%51.2%  
Selling, general and administrative  116.6118.550.310.117,160.819,024.2
Research and development  2.38.88.55.79,945.011,866.6
Other operating expenses     -15.8-10,473.1-30,890.7
EBITDA   [+]-25.0-84.5-37.516.6-16,603.345.3
            EBITDA margin  -23.6%-155.7%-175.1%51.2%  
Depreciation and amortization  35.813.00.00.029.445.3
EBIT   [+]-60.8-97.5-37.516.6-16,632.70.0
            EBIT margin  -57.4%-179.6%-175.1%51.2%  
Non-recurring items   [+]35.75.1    
Interest income, net   [+]-27.0-6.1   258.7
Other income (expense), net   [+]0.75.7-0.13.1-75.6-258.7
Pre-tax income  -122.8-103.0-37.619.7-16,708.30.0
Income taxes  2.4-0.10.20.00.00.0
            Tax rate   0.1% 0.0%0.0% 
Net income  -125.2-103.0-37.819.7-16,708.3-25,283.0
            Net margin  -118.2%-189.8%-176.6%60.7%  
   
Basic EPS   [+]($1.89)($1.67)($1.16)$0.63($0.55)($0.84)
Diluted EPS   [+]($1.89)($1.66)($1.16)$0.60($0.55)($0.84)
   
Shares outstanding (basic)   [+]66.461.832.631.430,449.730,092.0
Shares outstanding (diluted)   [+]66.461.932.632.830,449.730,092.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy